The FAMMM syndrome: Epidemiology and surveillance strategies

Cancer Investigation

Volumn 18, Issue 7, 2000, Pages 670-680

  Fusaro, Ramon M ^a   Lynch, Henry T ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYACETONE; SUNSCREEN;

ALGORITHM; ARTICLE; BIOLOGY; CANCER EPIDEMIOLOGY; CANCER FAMILY; CANCER MORTALITY; CANCER RISK; DNA DAMAGE; DNA REPAIR; EPIDEMIC; GENE MUTATION; GENETIC SCREENING; HUMAN; MELANOMA; MOLECULAR GENETICS; MULTIPLE CANCER; ONSET AGE; PATHOGENESIS; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RISK FACTOR; SUNLIGHT; SUNLIGHT PROTECTION; ULTRAVIOLET RADIATION;

EID: 0033810309     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357900009032833     Document Type: Article

References (88)

1. The emerging epidemic of melanoma and squamous cell skin cancer
2. Epidemiology and prognostic factors in malignant melanoma
3. Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma
4. Cutaneous melanoma
5. The worldwide incidence of malignant melanoma
6. Racial differences in melanoma incidence
7. Hereditary and malignant melanoma: Implications for cancer detection
8. Family history in an oncology clinic: Implications for cancer genetics
9. Family studies of malignant melanoma and associated cancer
10. Hereditary factors in carcinoma
11. A questionnaire survey of midwest dermatologists in the clinical genetic aspects of patients with multiple nevi
12. The clinical use of genealogic techniques in cancer investigations: A questionnaire survey
13. A new cutaneous phenotype in familial malignant melanoma
14. Familial atypical multiple mole melanoma syndrome
15. Origin of familial malignant melanoma from heritable melanocytic lesions: B-K mole syndrome
16. Precursor lesions in familial melanoma
17. Familial atypical multiple mole melanoma (FAMMM) syndrome: Genetic heterogeneity and malignant melanoma
18. Familial atypical multiple mole melanoma (FAMMM) syndrome: Segregation analysis
19. Risk of cutaneous melanoma associated with a family history of the disease
20. The hereditary variant of malignant melanoma
21. Cutaneous malignant melanoma and familial dysplastic nevi: Evidence for autosomal dominance and pleiotropy
22. Epiluminescence microscopy for diagnosis of doubtful melanocytic lesions. Comparison of the ABCD rule of dermatoscopy and a new seven-point check list based on pattern analysis
23. Epiluminescence microscopy, a useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists
24. Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features
25. Tumour spectrum in the FAMMM syndrome
26. Precursors to malignant melanoma, NIH Consensus Conference report
27. National Institutes of Health consensus report on precursors to malignant melanoma: A difference in opinion
28. Familial malignant melanoma
29. Hereditary melanoma and the dysplastic nevus syndrome: The risk of cancers other than melanoma
30. Risk of melanoma and other cancers in melanoma-prone families
31. Systemic cancer and the FAMMM syndrome
32. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
33. Linkage analysis in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families. Effect of nevus count
34. Confirmation of chromosome 9p linkage in familial melanoma
35. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity
36. Molecular genetics of familial cutaneous melanoma
37. Molecular biology of human melanoma development and progression
38. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
39. Germline p 16 mutations in familial melanoma
40. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families
41. Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma
42. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16(1NK4) mutations
43. Brief report: A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN 2 tumor suppressor gene
44. Familial melanoma and pancreatic cancer
45. Excess cancer mortality in six Dutch pedigrees with the familial atypical mole melanoma syndrome from 1830-1994
46. Ocular melanoma in families with dysplastic nevus syndrome
47. Primary choroidal and cutaneous melanomas, bilateral choroidal melanomas and familial occurrence of melanomas
48. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility
49. The pathogenesis of melanoma induced by ultraviolet radiation
50. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: Reduced DNA repair capacity and increased DNA mutability
51. Depression of specific genes promotes DNA repair and mutagenesis in Escherichia colt
52. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli
53. Multi-level modeling of geographically aggregated health data: A case study on malignant melanoma mortality and UV exposure in the European community
54. Incidence of malignant melanoma of the skin in Norway, 1955-1989: Associations with solar ultraviolet radiation, income and holidays abroad
55. Photophysics, photochemistry, and photobiology
56. Chronic low-dose UVA irradiation induces local suppression of contact hypersensitivity, Langerhans cell depletion and suppressor cell activation in C3H/HeJ mice
57. Ultraviolet radiation-induced skin tumors in a South American opossum (Monodelphis domaestica)
58. Animal model for ultraviolet radiation-induced melanoma: Platyfish-swordtail hybrid
59. Southern traveling habits with special reference to tumour site in Swedish melanoma patients
60. Dysplastic nevi and other risk markers for melanoma
61. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: A case-control study in a Mediterranean population
62. Prevalence of melanocytic nevi and freckles in young Israeli males; correlation with melanoma incidence in Jewish migrants: Demographic and host factors
63. Clinical results using informatics to evaluate hereditary cancer risks
64. Using data mining to characterize DNA mutations by patients' clinical features
65. Automated detection of hereditary syndromes using data mining
66. Digital dermoscopy analysis for the differentiation of atypical nevi and early melanoma
67. Hereditary factors in pancreatic cancer
68. The sunscreen and melanoma controversy
69. Sunscreens may not protect against melanoma
70. Regular use of sunscreen on vitamin D levels
71. Sun protection by families at the beach
72. What's new in skin cancer, a review of recent developments in research and public outreach
73. Sunscreens: Friend or foe?
74. Cutaneous malignant melanoma and exposure to sunlamps and sunbeds: A descriptive study in Belgium
75. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps
76. Use of sunbeds or sunlamps and malignant melanoma in southern Sweden
77. Photostability testing of avobenzone
78. A guide to sunscreens
79. Protection against long ultraviolet and/or visible light with topical dihydroxyacetone
80. Turgo-PUVA: Dihydroxyacetone-enhanced photochemotherapy for psoriasis
81. Sunlight protection in normal skin
82. Skin optics of melanoid stains versus natural melanin
83. Alteration of skin surface protein with dihydroxyacetone: A useful application of the Maillard browning reaction
84. Sun protection by families at the beach
85. Non-carcinogenecity of dihydroxyacetone by skin painting